Options for renal replacement therapy: Special considerations

Seminars in Nephrology

Volumn 17, Issue 3, 1997, Pages 176-187

  Becker, B N ^a   Stone, W J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DIABETES MELLITUS; DIALYSIS; ELDERLY CARE; HEMODIALYSIS; HOME DIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL;

HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030915897     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Port FK: Worldwide demographics and future trends in end-stage renal disease. Kidney Int 43:S4-S7, 1993
2. Ismail N, Becker BN: Treatment options and strategies in uremia: current trends and future directions. Semin Nephrol 14:282-299, 1994
3. United States Renal Data System, 1996 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, March 1996
4. United States Renal Data System, 1996 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, March 1996
5. Hutchinson TA, Thomas DC, Lemieux JC et al: Prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 26:44-51, 1984
6. Port FK, Wolfe RA, Mauger EA, et al: Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA 270:1339-1343, 1993
7. Burton PR, Walls J: Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and renal transplantation. Lancet 1:1115-1119, 1987
8. Minetti L, Civati G, Brando B, et al: A comparison between maintenance hemodialysis and transplantation in the treatment of end-stage renal disease. Transplant Proc 17:2831, 1985 (Suppl 2)
9. Garcia-Garcia G, Deddens JA, D'Achiardi-Rey R, et al: Results of treatment in patients with end-stage renal disease: A multivariate analysis of risk factors and survival in 341 successive patients. Am J Kidney Dis 5:10-18, 1985
10. Maiorca R, Vonesh E, Cancarini GC, et al: A six-year comparison of patient technique survivals on CAPD and HD. Kidney Int 34:518-524, 1988
11. Gokal R, Jakubowskic K, King J, et al: Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of prospective multicenter study. Lancet 14:1105-1109, 1987
12. Serkes KD, Blagg CR, Nolph KD, et al: Comparison of patient and technique survival continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: A multicenter study. Peritoneal Dialysis Int 10:15-19, 1990
13. Cavalli PL, Vigilino G, Goia F, et al: CAPD versus hemodialysis (HD): 7 years of experience, in Khanna R, Nolph KD, Prowant BF, et al (eds): Advances in Continuous Ambulatory Peritoneal Dialysis. Toronto, Peritoneal Dialysis Bulletin, Inc. 1989, pp 52-55
14. United States Renal Data System, 1994 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, March 1994
15. Nolph KD: Comparison of continuous ambulatory peritoneal dialysis and hemodialysis. Kidney Int 33:S123-131, 1988
16. Maiorca R, Vonesh EF, Cavalli PL, et al: A multicenter selection adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Peritoneal Dialysis Int 11:118-127, 1991
17. United States Renal Data System, 1995 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, March 1995
18. Evans RW, Manninen DL, Garrison LP, et al: The quality of life of patients with end-stage renal failure. N Engl J Med 312:553-559, 1985
19. Morris PL, Jones B: Transplantation versus dialysis: A study of quality of life. Transplant Proc 20:23-26, 1988
20. Simmons RG, Anderson CR, Abress LK: Quality of life and rehabilitation differences among four ESRD therapy groups. Scand J Urol Nephrol Suppl 131:7-22, 1990
21. Nissenson AR, Maida CA, Katz AH, et al: Psychosocial adaptation of CAPD and centre hemodialysis patients, in Khanna R, Nolph KD, Prowant BF, et al (eds): Advances in Continuous Ambulatory Peritoneal Dialysis. Toronto, Peritoneal Dialysis Bulletin, Inc., 1986, pp 42-56
22. Stout J, Gokal R, Hillier V, et al: Quality of life of high risk and elderly dialysis patients in the U.K. Nephrol Dial Transplant 16:674-677, 1987
23. Auer J, Gokal R, Stout JP, et al: The Oxford-Manchester study of dialysis patients. Scand J Urol Nephrol Suppl 131:31-37, 1990
24. Stout JP, Auer J, Kinsey J, et al: Sexual and marital relationships and dialysis - Patient's viewpoint. Perit Dial Bull 7:92-101, 1987
25. Suskolve V, Kaplan-DeNour A: Psychosocial adjustment of home hemodialysis, CAPD, and hospital dialysis patients and their spouses. Nephron 47:266-273
26. Julius M, Kneisley J, Carpentier-Alting P, et al: A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study). Arch Intern Med 149:839-842, 1989
27. Ismail N, Hakim RM, Helderman JH: Renal replacement therapies in the elderly: Part II. Renal transplantation. Am J Kidney Dis 23:1-15, 1994
28. Pirson Y: The diabetic patient with ESRD: How to select the modality of renal replacement. Nephrol Dial Transplant 11:1511-1513, 1996
29. Lippert J, Ritz E, Schwarzbeck A, Schneider P: The rising tide of endstage renal failure from diabetic nephropathy type II-An epidemiological analysis. Nephrol Dial Transplant 10:462-467, 1995
30. United States Renal Data System, 1995 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, March 1995
31. Valdenabano F, Jones EHP, Mallick NP: Report on management of renal failure in Europe XXIV. Nephrol Dial Transplant 10:10-25, 1993 (Suppl 5)
32. Parfrey PS, Foley RN, Harriett JD, et al: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
33. Hirschl MM, Derfler K, Heinz G, et al: Long-term follow-up of renal transplantation in type 1 and type 2 diabetic patients. Clin Invest 70:917-921, 1992
34. Gorlen T, Abdelnoor M, Enger E, et al: Long term morbidity and mortality after kidney transplantation. Scand J Urol Nephrol 26:397-401, 1992
35. Khanna R: Dialysis considerations for diabetic patients. Kidney Int 43:S58-S64, 1993 (Suppl 40)
36. Kemperman FAW, Van Leusen R, Van Liebergen FJHM, et al: Continuous ambulatory peritoneal dialysis in patients with diabetic nephropathy. Neth J Med 38:326-345, 1991
37. Zheng-Yi Y, Balaskas E, Gupta A, et al: CAPD: An effective treatment for diabetics with end-stage renal disease. Semin Dial 5:181-188, 1992
38. Manske CL, Wang Y, Wilson RF, et al: Coronary revascularization in type I diabetic patients with nephropathy. Lancet 340:998-1002, 1992
39. Becker BN, Becker YT, Neyra R, et al: Renal failure and perioperative risk. Am J Kidney Dis (submitted for publication)
40. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 44:617-621, 1993
41. Kasiske BL, Ramos EL, Gaston RS, et al: The evaluation of renal transplant candidates: Clinical practice guidelines. J Am Soc Nephrol 6:1-34, 1995
42. American Diabetes Association: Pancreas transplantation for patients with diabetes mellitus. Diabetes Care 16:21, 1993 (Suppl 2)
43. Pirsch JD, Andrews C, Hricik DE, et al: Pancreas transplantation for diabetes mellitus. Am J Kidney Dis 27:444-450, 1996
44. Ortiz C, Meneses R, Jaffe JA: Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 34:248-253, 1988
45. Kimmel PL, Uman WO, Simmens SJ, et al: Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 44:373-378, 1993
46. Rao TKS, Friedman EA, Nicastri AD: The type of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316:1062-1068, 1987
47. Breyer JA, Harbison MA: Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 21:23-25, 1993
48. Ismail N, Hakim RM, Oreopoulos DG, Patrikarea A: Renal replacement therapies in the elderly: Part 1. hemodialysis and chronic peritoneal dialysis. Am J Kidney Dis 22:759-782, 1993
49. Fourchez T, Moriniere P, St Priest A: Outcome of vascular access for hemodialysis in the elderly (>75 years). Proc Euro Dial Transplant Assoc 27: 160, 1990 (abstr)
50. Didlake R, Traju S, Rhodes RS, Bower J: Dialysis access in patients older than 65 years, in Sommer BG, Henry ML (eds): Vascular Access for Hemodialysis-II. Boston, MA, W.L. Gore and Associates, Precept Press, 1991, pp 166-172
51. Posen G, Lam E, Rappaport A: CAPD in Canada in 1982. Perit Dial Bull 4:72-74, 1984
52. Nissenson AR: Chronic peritoneal dialysis in the elderly. Geriatr Nephrol Urol 1:3-12, 1991
53. Gentile DE and the Geriatric Advisory Committee: Peritoneal dialysis in geriatric patients: A survey of clinical practice. Adv Pent Dial 6:29-32, 1990 (suppl 6)
54. Pirsch JD, Stratta RJ, Armbrust MJ, et al: Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age. Transplantation 47:259-261, 1989
55. Tesi RJ, Elkhammas EA, Davies EA, et al: Renal transplantation in older people. Lancet 343:461-464, 1994
56. Miller RA: The cell biology of aging: immunological model. J Gerontol 44:B4-B8, 1989
57. Fox RA: Immunology of aging, in Brockelhurst JC (ed): Textbook of Geriatric Medicine and Gerontology. New York, NY, Churchill Livingstone, 1985, pp 82-104
58. Herberman R, Kjeu J, Kay H: Natural killer cells: Characteristics and regulation of activity. Immunol Rev 44:43-70, 1979
59. Alonso MC, Navarette C, Solana R, et al: Differential expression of HLA-DR and HLA-DQ antigens on normal cells of the myelomonocytic lineage. Tissue Antigens 26:310-316, 1985
60. Crawford J, Eye MK, Cohen HJ: Evaluation of monoclonal gammopathies in the well elderly. Am J Med 82:39-45, 1987
61. Shah B, First MR, Munda R, et al: Current experience with renal transplantation in older patients. Am J Kidney Dis 12:516-523, 1988
62. United States Renal Data System, 1993 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, March 1993
63. Moorhead JF, Baillod RA, Hopewell JP, et al: Survival rates of patients treated by home and hospital dialysis and cadaveric renal transplantation. Br Med J 4:83-85, 1970
64. Price JDE, Ashby KM, Reeve CE: Results of 12 years' treatment of chronic renal failure by dialysis and transplantation. Can Med Assoc J 118: 263-266, 1978
65. Williams GW, Weller JM, Ferguson CW, et al: Survival of end-stage renal disease patients: Age-adjusted differences in treatment outcomes. Kidney Int 24:691-693, 1983
66. Wing AJ: Survival on integrated therapies-What assumptions shall we make? Am J Kidney Dis 4:224-232, 1984
67. Prowant B, Nolph KD, Dutton S, et al: Actuarial analysis of patient survival and dropout with various end-stage renal disease therapies. Am J Kidney Dis 3:27-31, 1983
68. Mailloux LU, Kapikian N, Napolitano B, et al: Home hemodialysis: Patient outcomes during a 24-year period of time from 1970 through 1993. Adv Renal Repl Ther 3:112-119, 1996
69. Bremer BA, McCauley CR, Wrona RM, et al: Quality of life in end-stage renal disease: A rexamination. Am J Kidney Dis 13:200-209, 1989
70. Kutner NG, Brogan D, Kutner MH: End-stage renal disease treatment modality and patients' quality of life. Am J Nephrol 6:396-402, 1986
71. Oberley ET, Schatell DR: Home hemodialysis: Survival, quality of life and rehabilitation. Adv Renal Repl Ther 3:147-153, 1996